Your browser doesn't support javascript.
loading
Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.
Song, Young Bin; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Kim, Jun Hyung; Lee, Sang Yeub; Choe, Yeon Hyeon; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon.
Affiliation
  • Song YB; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Clin Cardiol ; 32(6): 321-6, 2009 Jun.
Article in En | MEDLINE | ID: mdl-19569068

Full text: 1 Database: MEDLINE Main subject: Tyrosine / Magnetic Resonance Imaging / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Myocardial Infarction / Myocardium Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Cardiol Year: 2009 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tyrosine / Magnetic Resonance Imaging / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Myocardial Infarction / Myocardium Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Cardiol Year: 2009 Type: Article